Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study (Q41134747)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 1, 1992
edit
Language Label Description Also known as
English
Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study
scientific article published on January 1, 1992

    Statements

    title
    Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    1316201
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316201
    retrieved
    12 September 2022
    Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study (English)
    1 reference
    stated in
    Crossref
    DOI
    10.3109/07357909209032763
    reference URL
    https://api.crossref.org/works/10.3109/07357909209032763
    retrieved
    4 December 2023

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q41134747&oldid=2023839862"